Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 9/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 8/20 | 0.52 |
| ▸ | HTT | P42858 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28071561 | 0.81 | KDM4E (0.58) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL1585224 | 0.78 | KDM4E (0.50) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL9350410 | 0.77 | ALDH1A1 (0.64) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL778272 | 0.77 | HPGD (0.52) | HPGDKDM4EALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL2964435 | 0.77 | KDM4E (0.48) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL3074991 | 0.76 | MAPT (0.56) | HPGDALDH1A1SMN1; SMN2CA12CA1 | |
| SCHEMBL28785454 | 0.76 | CES2 (0.58) | HPGDKDM4EALDH1A1MAPTLMNA | |
| SCHEMBL1307730 | 0.75 | KDM4E (0.47) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL27751705 | 0.74 | ALDH1A1 (0.86) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL3074700 | 0.74 | HPGD (0.56) | HPGDKDM4EALDH1A1SMN1; SMN2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 475 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060012-A | Preparation method of eplerenone and intermediate thereof | 江西百思康瑞药业有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2025059962-A1 | ALS INHIBITOR SULFONYLUREA HERBICIDES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 成都新朝阳作物科学股份有限公司 | 2025-03-27 | — | — | WO | claimed |
| CN-119661444-A | ALS inhibitor sulfonylurea herbicide and preparation method and application thereof | 成都新朝阳作物科学股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119191924-A | Synthesis method of tetra-substituted-1, 3-diene dicarboxylic acid | 兰州大学 | 2024-12-27 | — | — | CN | claimed |
| CN-119161341-A | Green synthesis method of polycyclic dihydroquinazolinone derivative with antiviral activity | 河北农业大学 | 2024-12-20 | — | — | CN | claimed |
| CN-119143756-A | Green synthesis method of polycyclic quinazolinone derivative with antiviral activity | 河北农业大学 | 2024-12-17 | — | — | CN | claimed |
| CN-117946028-B | Synthesis method of 1, 4-benzothiazepine compound | 南通大学 | 2024-09-24 | — | — | CN | claimed |
| CN-118562273-A | Long glass fiber reinforced polycarbonate and preparation method thereof | 万华化学（宁波）有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118561858-A | High water-solubility phthalocyanine modified by amine oxide group, preparation and application thereof | 福州大学 | 2024-08-30 | — | — | CN | claimed |
| CN-117946028-A | Synthesis method of 1, 4-benzothiazepine compound | 南通大学 | 2024-04-30 | — | — | CN | claimed |
| CN-114369117-B | Phosphine-gold (I) -sulfur complex and preparation method and application thereof | 华中科技大学同济医学院附属同济医院 | 2024-02-23 | — | — | CN | claimed |
| CN-116969903-B | Efficient preparation method of thiazate | 昊维联众生物医药技术(天津)有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-116969903-A | Efficient preparation method of thiazate | 昊维联众生物医药技术(天津)有限公司 | 2023-10-31 | — | — | CN | claimed |
| CN-114369117-A | Phosphine-gold (I) -sulfur complex and preparation method and application thereof | 华中科技大学同济医学院附属同济医院 | 2022-04-19 | — | — | CN | claimed |
| CN-112358464-A | Preparation method of Barosavir intermediate | 南京法恩化学有限公司 | 2021-02-12 | — | — | CN | claimed |
| US-10191398-B2 | Electrophotographic photoconductor, image forming apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2019-01-29 | — | — | US | claimed |
| CN-122060012-A | Preparation method of eplerenone and intermediate thereof | 江西百思康瑞药业有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12606543-B2 | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto | MINDSET PHARMA INC. (CA) | 2026-04-21 | — | — | US | disclosed |
| US-4018793-A | ANALGESICS, ANTIINFLAMMATORY, ANTIPYRETICS | WARNER-LAMBERT COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-3971814-A | ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS | WARNER-LAMBERT COMPANY (US) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606543-B2 | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto | HTR6, CNR1, HTR3C | HPGD 1865/4885KDM4E 4090/4885ALDH1A1 1626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.